Grand Pharmaceutical Group Dividends and Buybacks
Dividend criteria checks 4/6
Grand Pharmaceutical Group is a dividend paying company with a current yield of 5.99% that is well covered by earnings.
Key information
6.0%
Dividend yield
0.01%
Buyback Yield
| Total Shareholder Yield | 6.0% |
| Future Dividend Yield | 6.7% |
| Dividend Growth | 24.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €0.260 |
| Payout ratio | 38% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, MX6A has been paying a dividend for less than 10 years.
Growing Dividend: MX6A's dividend payments have increased, but the company has only paid a dividend for 6 years.
Dividend Yield vs Market
| Grand Pharmaceutical Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (MX6A) | 6.0% |
| Market Bottom 25% (DE) | 1.7% |
| Market Top 25% (DE) | 4.8% |
| Industry Average (Pharmaceuticals) | 1.4% |
| Analyst forecast (MX6A) (up to 3 years) | 6.7% |
Notable Dividend: MX6A's dividend (5.99%) is higher than the bottom 25% of dividend payers in the German market (1.73%).
High Dividend: MX6A's dividend (5.99%) is in the top 25% of dividend payers in the German market (4.82%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (37.7%), MX6A's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (62.8%), MX6A's dividend payments are covered by cash flows.